Gilead Sciences to Present at the 3rd Annual Evercore ISI HealthCONx Conference on Wednesday, December 2, 2020
November 23 2020 - 7:00PM
Business Wire
-- Conference Call and Webcast to Follow
--
Gilead Sciences, Inc. (Nasdaq: GILD) announced today that
Johanna Mercier, Chief Commercial Officer, and Merdad Parsey, MD,
PhD, Chief Medical Officer, will participate in a fireside chat at
the 3rd Annual Evercore ISI HealthCONx Conference on Wednesday,
December 2 at 11:20 a.m. Eastern Time.
The live webcast can be accessed at the company’s investors page
at investors.gilead.com. Please connect to the company’s website at
least 15 minutes prior to the start of the presentation to ensure
adequate time for any software download that may be required to
listen to the webcast. The replay will be available for 14 days
following the presentation.
About Gilead
Gilead Sciences, Inc. is a research-based biopharmaceutical
company that discovers, develops and commercializes innovative
medicines in areas of unmet medical need. The company strives to
transform and simplify care for people with life-threatening
illnesses around the world. Gilead has operations in more than 35
countries worldwide, with headquarters in Foster City,
California.
For more information on Gilead Sciences, please
visit the company’s website at www.gilead.com, follow Gilead on
Twitter (@GileadSciences) or call Gilead Public Affairs at
1-800-GILEAD-5 or 1-650-574-3000.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201123006303/en/
Douglas Maffei, Ph.D. Investor Relations (650) 574-3000
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gilead Sciences (NASDAQ:GILD)
Historical Stock Chart
From Apr 2023 to Apr 2024